# Oobli

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/oobli

- Industry: Food
- Headquarters: Davis, US
- Website: www.oobli.com/
- Total disclosed funding: $50M
- Latest round: Series B (Feb 13, 2025)
- Investors on record: 12

## About

Oobli, Inc. is a US-based company specializing in innovative sweet proteins that provide a sugar alternative while ensuring improved taste and health benefits. The firm focuses on sustainability and caters to health-conscious consumers.Oobli, Inc. is engaged in the development of sweet proteins as a sugar substitute. Founded in 2014 in Davis, US, the company has undergone strategic pivots to enhance its product offerings. The firm was founded by Jason Ryder, who has a history of entrepreneurship. The latest funding round was a Series B, raising USD 18.000 mn, bringing the total amount raised to USD 18.000 mn, with a current company valuation of USD 155.689 mn. Notable investors in this round include B37 Ventures, Ingredion Ventures, Khosla Ventures, Lever VC, Piva Capital, and Sucden Ventures.Oobli specializes in innovative sweeteners known as sweet proteins, which serve as effective sugar replacements without compromising taste or health. Their primary products include milk chocolate and dark chocolate varieties that utilize these sweet proteins, appealing to health-conscious individuals, diabetics, and low-carb lifestyle enthusiasts. Oobli markets its offerings primarily in North America and Europe, targeting both individual consumers and food manufacturers looking to innovate their products.Oobli generates revenue through direct sales of its sweet protein products to consumers and retailers, as well as partnerships with food manufacturers. The company sells individual products via its website and engages retailers in bulk purchasing agreements. Its flagship offerings, including Oobli Milk Chocolate and Dark Chocolate, are marketed as premium alternatives to traditional chocolate. Oobli also provides subscription services to enhance customer engagement and loyalty.Oobli is planning the launch of new sweet protein products, with specific release dates to be announced. The company aims to expand into new markets, particularly targeting regions in Asia and South America by the end of 2024. The recent Series B funding of USD 18.000 mn will support its product development and market expansion strategies, allowing Oobli to enhance its production capabilities and broaden its distribution network.

## Funding rounds

- Series B, Feb 13, 2025, $18M — Khosla Ventures, B37 Ventures, Lever VC, Ingredion Ventures, Piva Capital, Sucden Ventures
- Series B, Feb 8, 2022, $25M — Khosla Ventures, Global Brain, SOSV, Alumni Ventures Group, IndieBio, Heinz Ventures, B37 Ventures-
- Series A, Jun 18, 2020, $6.9M — Khosla Ventures, SOSV, Alumni Ventures Group, IndieBio, Heinz Ventures
- Seed, Jan 20, 2017 — SOSV, IndieBio
- Seed, Feb 11, 2016 — SOSV, IndieBio

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Seed, Series A, Series B
- IndieBio (https://capitalatlas.ai/funds/indiebio) — Seed, Series A, Series B
- Khosla Ventures (https://capitalatlas.ai/funds/khosla-ventures) — Series A, Series B
- Alumni Ventures Group (https://capitalatlas.ai/funds/alumni-ventures-group) — Series A, Series B
- Heinz Ventures (https://capitalatlas.ai/funds/heinz-ventures) — Series A, Series B
- Global Brain (https://capitalatlas.ai/funds/global-brain) — Series B
- B37 Ventures- — Series B
- B37 Ventures (https://capitalatlas.ai/funds/b37-ventures) — Series B
- Lever VC (https://capitalatlas.ai/funds/lever-vc) — Series B
- Ingredion Ventures — Series B
- Piva Capital — Series B
- Sucden Ventures (https://capitalatlas.ai/funds/sucden-ventures) — Series B